Literature DB >> 35371947

Concordance and survival implications of preoperative subclassification of T3 rectal cancers by depth of mesorectal invasion using a 5-mm cut-off point with endorectal ultrasound and magnetic resonance imaging.

Stephanie García Botello1,2, Rosa Martí Fernández1, Coral Cozar Lozano1, Salvador Campos Salher3, Jose Martín Arévalo1,2, David Moro Valdezate1,2, Vicente Pla Martí1,2, Alejandro Espí Macías1,2.   

Abstract

Background: Validated rectal cancer staging groups T3 tumours in a single stage and depth of mesorectal invasion subclassification is not standard practice. Our aim is to report concordance between magnetic resonance imaging (MRI) and endorectal ultrasound (ERUS) for preoperative staging of T3 rectal tumours using a 5-mm cut-off point and possible survival implications.
Methods: Prospective cohort study including patients staged preoperatively as cT3 by ERUS or magnetic resonance imaging. The maximum depth of penetration beyond the outer longitudinal muscle layer was measured according to a 5-mm cut-off point. Concordance rate and Kappa coefficient were calculated for both techniques. Primary end-points were disease free survival and overall survival (OS) for both groups.
Results: A total of 97 patients were included. Disease-free survival in depth of mesorectal invasion ≤5 and >5 mm measured by ERUS was 130.80 (119.20-142.30) vs. 88.38 (56.13-120.64) months (P=0.020), respectively, and 129.90 (117.90-141.90) vs. 93.60 (64.50-122.70) months (P=0.045) when measured by magnetic resonance imaging. Depth of mesorectal invasion ≤5 mm measured by ERUS and MRI was a prognostic factor for both OS [ERUS P=0.009; MRI P=0.019] and DFS (ERUS P=0.026; MRI P=0.054) after Cox regression analysis. Conclusions: T3 subclassification above and below 5mm is feasible by ERUS, shows good concordance with validated magnetic resonance and can easily be incorporated into the diagnostic workup for these patients with possible survival implications. 2022 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  Depth of mesorectal invasion (DMI); T3 tumours; endorectal ultrasound (ERUS); magnetic resonance imaging (MRI); rectal cancer

Year:  2022        PMID: 35371947      PMCID: PMC8923861          DOI: 10.21037/qims-21-880

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  27 in total

1.  Prognostic stratification by extramural depth of tumor invasion of primary rectal cancer based on the Radiological Society of North America proposal.

Authors:  Seung Hyun Cho; Seung Ho Kim; Ji Hea Bae; Yun-Jin Jang; Hye Jung Kim; Dakeun Lee; Jun Seok Park
Journal:  AJR Am J Roentgenol       Date:  2014-06       Impact factor: 3.959

2.  The prognostic inhomogeneity in pT3 rectal carcinomas.

Authors:  S Merkel; U Mansmann; M Siassi; T Papadopoulos; W Hohenberger; P Hermanek
Journal:  Int J Colorectal Dis       Date:  2001-09       Impact factor: 2.571

3.  Extent of mesorectal spread and involvement of lateral resection margin as prognostic factors after surgery for rectal cancer.

Authors:  S J Cawthorn; D V Parums; N M Gibbs; R P A'Hern; S M Caffarey; C I Broughton; C G Marks
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

4.  MRI identified prognostic features of tumors in distal sigmoid, rectosigmoid, and upper rectum: treatment with radiotherapy and chemotherapy.

Authors:  Sarah Burton; Gina Brown; Ian Daniels; Andy Norman; Ian Swift; Muti Abulafi; Andy Wotherspoon; Diana Tait
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-06-01       Impact factor: 7.038

5.  Predicting oncologic outcomes by stratifying mesorectal extension in patients with pT3 rectal cancer: a Japanese multi-institutional study.

Authors:  Yoshito Akagi; Kazuo Shirouzu; Shin Fujita; Hideki Ueno; Yasumasa Takii; Koji Komori; Masaaki Ito; Kenichi Sugihara
Journal:  Int J Cancer       Date:  2012-01-03       Impact factor: 7.396

6.  Value of endorectal ultrasonography in measuring the extent of mesorectal invasion and substaging of T3 stage rectal cancer.

Authors:  Guangxi Zhong; Yi Xiao; Weixun Zhou; Weidong Pan; Qingli Zhu; Jing Zhang; Yuxin Jiang
Journal:  Oncol Lett       Date:  2017-09-06       Impact factor: 2.967

7.  Prognostic heterogeneity of endosonographic T3 rectal cancer.

Authors:  Pedro Esclapez; Eduardo Garcia-Granero; Blas Flor; Stephanie García-Botello; Andres Cervantes; Samuel Navarro; Salvador Lledó
Journal:  Dis Colon Rectum       Date:  2009-04       Impact factor: 4.585

8.  Clinical implications of quantification of mesorectal tumor invasion by endoscopic ultrasound: All T3 rectal cancers are not equal.

Authors:  Gavin C Harewood; K Shiva Kumar; Jonathan E Clain; Michael J Levy; Heidi Nelson
Journal:  J Gastroenterol Hepatol       Date:  2004-07       Impact factor: 4.029

9.  Prognostic subdivision of ypT3 rectal tumours according to extension beyond the muscularis propria.

Authors:  S Merkel; K Weber; V Schellerer; J Göhl; R Fietkau; A Agaimy; W Hohenberger; P Hermanek
Journal:  Br J Surg       Date:  2014-01-29       Impact factor: 6.939

10.  The depth of tumor invasion beyond the outer border of the muscularis propria as a prognostic factor for T3 rectal/rectosigmoid cancer.

Authors:  Kiyohito Yoshida; Kazuhiko Yoshimatsu; Taisuke Otani; Hajime Yokomizo; Kenji Ogawa
Journal:  Anticancer Res       Date:  2008 May-Jun       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.